Expertise in
5
conditions

Silvia Govi

Milan, IT 
Expertise in
5
conditions
Milan, IT 

Overview

Silvia Govi practices practicing medicine in Milan, Italy.

Ms. Govi is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, and Marginal Zone Lymphoma (MZL).

She is actively involved in clinical research, co-authoring 22 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Milan, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

High-dose Sequential Chemotherapy and Rituximab (R-HDS) in Patients With Systemic B-cell Lymphoma With Central Nervous System Involvement at Diagnosis or Relapse
High-dose Sequential Chemotherapy and Rituximab (R-HDS) in Patients With Systemic B-cell Lymphoma With Central Nervous System Involvement at Diagnosis or Relapse
Enrollment Status: Completed
Publish Date: December 10, 2024
Intervention Type: Drug
Study Drug: High-Dose Sequential Chemotherapy and Autologous Transplant
Study Phase: Phase 2
A Phase II Trial to Evaluate the Safety and Activity of Single-agent Lenalidomide Given as Maintenance Therapy After Response to Second-line Therapy in Patients With Relapsed DLBCL, Not Eligible for High-dose Chemotherapy and ASCT (Autologous Stem-Cell Transplantation)
A Phase II Trial to Evaluate the Safety and Activity of Single-agent Lenalidomide Given as Maintenance Therapy After Response to Second-line Therapy in Patients With Relapsed DLBCL, Not Eligible for High-dose Chemotherapy and ASCT (Autologous Stem-Cell Transplantation)
Enrollment Status: Completed
Publish Date: April 10, 2024
Intervention Type: Drug
Study Drug: Lenalidomide
Study Phase: Phase 2
View 1 Less Clinical Trial

22 Total Publications

Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum.
Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum.
Journal: Blood advances
Published: January 07, 2020

Frequently Asked Questions about Silvia Govi

Is Silvia Govi a top-rated expert for B-Cell Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Silvia Govi is classified as an Distinguished expert for B-Cell Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Silvia Govi participate in research or clinical trials?

Yes. Silvia Govi has published 22 articles and abstracts on conditions like B-Cell Lymphoma. You can view a list of Silvia Govi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Govi's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile